Related Experiment Videos
Intranasal sumatriptan for the acute treatment of migraine in children
1Neuropediatric Department, University Hospital for Children and Adolescents, Erlangen, Germany. Michael.Ueberall@kinder.med.uni-erlangen.de
Insights
Sumatriptan nasal spray effectively reduced migraine pain and associated symptoms in children. This study demonstrates sumatriptan
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
- Migraine Pathophysiology
Background:
- Sumatriptan is an established adult migraine therapy.
- Pediatric migraine treatment efficacy remains under-investigated.
Purpose of the Study:
- To evaluate sumatriptan nasal spray's efficacy in pediatric migraine patients.
- To assess pain reduction and symptom relief in children using sumatriptan.
Main Methods:
- Randomized, double-blind, placebo-controlled crossover trial.
- 14 children (ages 6.4-9.8) with migraine participated.
- Sumatriptan nasal spray was administered and compared to placebo.
Main Results:
- Significant pain intensity reduction observed with sumatriptan (12/14 children) versus placebo (6/14 children; p=0.031).
- Complete headache relief achieved in 9/14 children with sumatriptan compared to 2/14 with placebo (p=0.016).
- Sumatriptan significantly decreased migraine-associated symptoms.
Conclusions:
- Sumatriptan nasal spray is effective for treating pediatric migraine.
- This treatment offers a viable option for migraine relief in children.
Abstract:
Sumatriptan is a highly effective treatment for migraine in adults but its efficacy in children has not been determined. Fourteen children with migraine (6.4 to 9.8 years of age; seven girls, six with aura) participated in a randomized double-blind placebo-controlled crossover study to evaluate the efficacy of sumatriptan nasal spray. After sumatriptan, 12 of 14 (versus 6 of 14 after placebo) reported a decrease in pain intensity (p = 0.031); complete headache relief was obtained in 9 of 14 after sumatriptan versus 2 of 14 after placebo (p = 0.016). Migraine-associated symptoms were also significantly reduced by sumatriptan.